Global Market Business Research Reports: Global Plasma Protein Therapeutics Market Report 2023: Market Size, Key Segments And Regions

The Plasma Protein Therapeutics Global Market Report 2023 by The Business Research Company, provides plasma protein therapeutics market overview across 60+ geographies in the seven regions - Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa for the 27 major global industries. The report covers a ten-year historic period – 2010-2021, and a ten-year forecast period – 2023-2032.

Learn More On The Plasma Protein Therapeutics Market:

https://www.thebusinessresearchcompany.com/report/plasma-protein-therapeutics-global-market-report

According to The Business Research Company’s Plasma Protein Therapeutics Global Market Report 2023, the market size is expected to grow from $26.25 billion in 2022 to $28.11 billion in 2023 at a compound annual growth rate (CAGR) of 7.1%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The global plasma protein therapeutics market size is expected to reach $35.84 billion in 2027 at a CAGR of 6.3%.

An increasing prevalence of autoimmune disorders is expected to propel the growth of the plasma protein therapeutics market going forward. An autoimmune disorder is a condition that emerges when the body's immune system attacks and destroys healthy body cells. Therapeutic plasma exchange is used to treat autoimmune diseases, which emerge when the body misidentifies a part of itself as foreign and produces proteins (known as autoantibodies) that attack the part of the body that is misidentified.

Get A Free Sample Of The Report (Includes Graphs And Tables):

https://www.thebusinessresearchcompany.com/sample_request?id=9213&type=smp

The plasma protein therapeutics market is segmented:

1) By Product: Immunoglobulin, Albumin, Coagulation Factor, C1-esterase Inhibitors, Other Products

2) By Route Of Administration: Intravenous, Subcutaneous

3) By Applications: Primary Immunodeficiency Disorder (PID), Idiopathic Thrombocytopenic Purpura, Secondary Immunodeficiency, Hereditary Angioedema, Other Applications

Product innovations are a key trend gaining popularity in the plasma protein therapeutic gaining market. Major companies operating in the plasma protein therapeutic sector are focused on innovative products to gain a competitive advantage in the market. For instance, November 2021, Biognosys a Switzerland-based biotechnology company launched an innovative next-Generation blood biomarker discovery solution. The service is intended to assist researchers in deciphering the complexities of the blood proteome and unlocking unbiased discoveries for pharmaceutical and diagnostic development, as well as precision medicine. A unique feature of both solutions is Biognosys' Hyper Reaction Monitoring (HRMTM) technology and its optimized Liquid Chromatography-Mass Spectrometry (LC-MS) workflow.

The plasma protein therapeutics market report table of contents includes:

1. Executive Summary

2. Plasma Protein Therapeutics Market Characteristics

3. Plasma Protein Therapeutics Market Trends And Strategies

4. Plasma Protein Therapeutics Market - Macro Economic Scenario

5. Plasma Protein Therapeutics Market Size And Growth

27. Plasma Protein Therapeutics Market Competitive Landscape And Company Profiles

28. Key Mergers And Acquisitions In The Plasma Protein Therapeutics Market

29. Plasma Protein Therapeutics Market Future Outlook and Potential Analysis

30. Appendix

Contact Us:
The Business Research Company
Europe: +44 207 1930 708

Asia: +91 88972 63534